Management of schizophrenia with medical disorders: cardiovascular, pulmonary, and gastrointestinal

The Psychiatric Clinics of North America
Delmar D ShortMaureen F McCarthy

Abstract

Medical illnesses are particularly common in patients who have schizophrenia and one of the major tasks for consultation-liaison psychiatrists, and others, is to determine which medications are safest in which co-morbid condition. The authors review the relative risks for various antipsychotics, especially focusing on cardiovascular, pulmonary, and gastrointestinal co-morbid illnesses. The authors further review the atypical antipsychotics' cardiovascular risks, especially for prolonging QT intervals, in trying to avoid the risk for torsades de pointes. The relative risk for anticholinergic actions for these medicines is also reviewed, as this is especially important in the medically ill or elderly. The authors also review the relative safety of antipsychotics in patients who have liver disease and pulmonary disease. Finally, the authors review specific drug interactions that may be problematic when treating the medically ill with atypical antipsychotics.

References

May 1, 1992·Acta Psychiatrica Scandinavica·P B Mortensen
Mar 1, 1992·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·M A CohnD Juan
Mar 1, 1987·Archives of General Psychiatry·S P RooseJ T Bigger
Dec 1, 1996·Psychiatric Services : a Journal of the American Psychiatric Association·B FelkerD Short
Jul 1, 1997·The Annals of Pharmacotherapy·D S Ravin, J W Levenson
Jun 1, 2000·Journal of Clinical Psychopharmacology·K N ChengappaR A Zoretich
Jul 4, 2002·Psychiatric Services : a Journal of the American Psychiatric Association·Barbara DickeyHocine Azeni
Jan 8, 2004·Journal of Clinical Psychopharmacology·Edmund P HarriganMichelle Middle
Feb 18, 2004·International Journal of Nursing Studies·Kuei-Ru ChouRu-Band Lu
Jun 24, 2004·Primary Care Companion to the Journal of Clinical Psychiatry·W VictorR Vieweg
Aug 24, 2004·Current Pharmaceutical Design·Pal Pacher, Valeria Kecskemeti
Sep 24, 2004·Psychosomatic Medicine·Caroline P CarneyBradley N Doebbeling
Mar 24, 2005·The New England Journal of Medicine·Edward W Boyer, Michael Shannon
Dec 13, 2005·American Heart Journal·Charles H HennekensDaniel E Casey
Feb 10, 2006·The Annals of Pharmacotherapy·Seema JabeenDavid R Gerber
Apr 25, 2006·Progress in Neuro-psychopharmacology & Biological Psychiatry·Tuba OzcanliAbdullah Sonsuz
May 25, 2006·Current Opinion in Psychiatry·Alex J Mitchell, Darren Malone
Jul 27, 2006·Journal of Psychiatric and Mental Health Nursing·E Muir-Cochrane
Aug 17, 2006·Harvard Review of Psychiatry·Michael T ComptonBenjamin G Druss
Oct 10, 2006·Journal of General Internal Medicine·Caroline P CarneyRobert F Woolson
Aug 30, 2008·Nordic Journal of Psychiatry·Hannu KoponenMatti Isohanni
Jan 16, 2009·The New England Journal of Medicine·Wayne A RayC Michael Stein

❮ Previous
Next ❯

Citations

Jan 7, 2016·International Journal of Mental Health Nursing·Kate CranwellTerence V McCann
May 1, 2015·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·Marie A LabouesseUrs Meyer

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here

Bradyarrhythmias

Bradyarrhythmias are slow heart rates. Symptoms may include syncope, dizziness, fatigure, shortness of breath, and chest pains. Find the latest research on bradyarrhythmias here.

Related Papers

Diabetic Medicine : a Journal of the British Diabetic Association
L A Adams, P Angulo
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
Harumi KitagawaAngela L Burnett
© 2022 Meta ULC. All rights reserved